The place of thrombolysis in the management of cerebral embolism after heart valve replacement.
Wardlaw
J M
JM
Medical Research Council, Western General Hospital, Edinburgh, United Kingdom.
D016001:Confidence Intervals; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000627:therapeutic use*; D015996:Survival Rate; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D013300:Streptokinase; D010959:Tissue Plasminogen Activator